Member Companies
Korea Pharmaceutical and Bio-Pharma Manufacturers Association
TOP
Regular Members
Company Overview
We are striving to make innovative, high-end biotherapeutics more patient-affordable through a game-changing mRNA platform. Our goal is to develop mRNA-encoded NK cell engagers with comparable or better efficacy, no toxicity and a far more convenient dosing regimen comparing with T cell engagers.
| Company Name | De novo Biotherapeutics | ||||
|---|---|---|---|---|---|
| CEO | Chang Hoon Choi | ||||
| home page | Number of employees | 2023year 21 m | Founding date | 2021-09-01 | |
| classification | Small Company, Small Bioventure | Sectors | CP Medicine | ||
Address Infomation
| Headquarters Address |
|
Headquarters TEL | Headquarters FAX | ||
|---|---|---|---|---|---|
| Factory Address |
|
Factory TEL | Factory FAX | ||
| Laboratory Address |
|
Laboratory TEL | Laboratory FAX |
Overseas local corporation
| country | Corporate name | Year entered | Field |
|---|---|---|---|